2018

Exclusive distributor of Med-Storm Innovation was founded in 1999. The main focus was to validate the PainMonitor also called Skin Conductance Algesimeter when assessing pain and nociceptive stimuli. The company has CE-certified indices to assess pain and nociceptive stimuli as well as awakening from anaesthesia. More recently there have been published studies showing that the PainMonitor device can be used to assess regional NerveBlock and Withdrawal symptoms, and Med-Storm Innovation has obtained CE-certification on these indices.